Back to mobile site

Piper Jaffray Upgrades Aslan Pharma (ASLN) to Overweight

December 2, 2019 9:02 AM EST Send to a Friend
Piper Jaffray analyst Edward Tenthoff upgraded Aslan Pharma (NASDAQ: ASLN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login